by Bob Yirka, Medical Xpress Credit: Jenriquecf/Wikimedia Commons, CC BY-SA 4.0 A team of researchers at the University of Pennsylvania has found that administration of a drug currently used to reduce cholesterol levels in the bloodstream can reduce the risk of developing proliferative diabetic retinopathy (PDR) from non-proliferative diabetic retinopathy (NPDR). In their paper published in JAMA Ophthalmology, the...
